Enantiomer-enantiomer interaction of a calcium channel antagonist, benidipine hydrochloride, during liver metabolism in the rat

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 2, 1999, Pages 121-126

  Kobayashi, Hiroyuki ^a   Kobayashi, S ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Benidipine hydrochloride; Calcium channel antagonist; Enantiomer enantiomer interaction; Liver metabolism; Rat

Indexed keywords

BENIDIPINE; CALCIUM ANTAGONIST;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG POTENCY; DRUG PROTEIN BINDING; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; LIVER METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RACEMIC MIXTURE; RAT; STEREOISOMERISM;

EID: 0032834138     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190356     Document Type: Article

References (13)

1. Muto K., Kuroda T., Kawato H., Karasawa A., Kubo K., Nakamizo N. (1988) : Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl-1-(phenyl methyl)-3-piperidinyl ester. Artzeimitellforschung., 38: 1662-1665.
2. Ishii A., Nishida K., Oka T., Nakamizo N. (1988) : Receptor binding properties of the new calcium antagonist benidipine hydrochloride. Artzeimitellforschung., 38: 1677-1680.
3. Ariëns E.J. (1993) : Nonchiral, homochiral and composite chiral drugs. Trends Pharmacol. Sci., 14: 68-75.
4. Kobayashi H., Kobayashi S., Inoue A., Oka T., Nakamizo N. (1988) : Gas Chromatographic method for the quantification of the new calcium antagonist benidipine hydrochloride in plasma using electron capture detection. Artzeimitellforschung., 38: 1730-1733.
5. Repond C., Bulgheroni A., Meyer U.A., Mayer J.M. Testa B. (1986) : Drug ligand binding of pyridine alkanamide to microsomal cytochrome P-450. Biochem. Pharmacol., 35: 2233-2240.
6. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) : Protein measurement with Folin phenol reagent. J. Biol. Chem., 193: 265-275.
7. Kobayashi H., Okumura S., Kosaka Y. et al. (1988) : Identification of benidipine hydrochloride metabolites in rats and dogs. Artzeimitellforschung., 38: 1753-1756.
8. Tokuma Y., Fujiwara T., Niwa T., Hashimoto T., Noguchi H. (1989) : Stereoselective disposition of nilvadipine a new dihydropyridine calcium antagonist, in the rat and dog. Res. Commun. Chem. Pathol. Pharmacol., 63: 249-262.
9. Rane A., Wilkinson G.R., Shand D.G. (1977) : Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J. Pharmacol. Exp. Ther., 200: 420-424.
10. Pang K.S., Rowland M. (1977) : Hepatic clearance of drugs: I. Theoretical considerations of a 'well-stirred' model and a 'parallel tube' model. Influence of hepatic blood flow, plasma and blood cell binding and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm., 5: 626-653.
11. Kobayashi H., Kobayashi S., Inoue A., Hirata T. (1990) : Pharmacokinetic study of benidipine hydrochloride in rats, dogs and monkeys. Xenobiot. Metabol. Dispos., 5: 111-119.
12. 14C-benidipine HCl in rats. Xenobiot. Metabol. Dispos., 5: 71-86.
13. Murphy P., Nickander R.C., Bellamy G.M., Kurtz. W.L. (1976): Effect of 1-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. J. Pharmacol. Exp. Ther., 199:415-422.